ClinicalTrials.Veeva

Menu

Treatment of Dentin Hypersensitivity Using Different Desensitizing Agents

A

Al-Azhar University

Status

Unknown

Conditions

Dentin Sensitivity

Treatments

Other: Theobromine
Other: Remin Pro

Study type

Interventional

Funder types

Other

Identifiers

NCT04340869
REC18-145

Details and patient eligibility

About

Treatment of Dentin Hypersensitivity Using Theobromine , Remin Pro , and Combination of Both Materials

Enrollment

30 estimated patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients that aged 18-50 years.
  • Patients in good general health.
  • Patients that have accessible teeth demonstrating signs of sensitivity.

Exclusion criteria

  • • Any chronic debilitating disease that could influence study outcomes.

    • Partial dentures, orthodontic appliances, implants or restorations in a poor state of repair that could influence study outcomes.
    • Intolerance or hypersensitivity to the study desensitizing agents or their ingredients.
    • Desensitising treatment or tooth bleaching within 8 weeks of screening.
    • Daily use of medications that might influence the perception of pain.(

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

30 participants in 3 patient groups

Theobromine
Experimental group
Description:
Natural extract from Cocoa
Treatment:
Other: Theobromine
Remin Pro
Active Comparator group
Description:
Fluoride , Hydroxyapatite , and Xylitol
Treatment:
Other: Remin Pro
Combination
Experimental group
Description:
Remin Pro and Theobromine
Treatment:
Other: Theobromine
Other: Remin Pro

Trial contacts and locations

1

Loading...

Central trial contact

Ebtsam Kassab

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems